Cargando…
Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis
Nephritis is a common manifestation of systemic lupus erythematosus, a condition associated with inflammation and iron imbalance. Renal tubules are the work horse of the nephron. They contain a large number of mitochondria that require iron for oxidative phosphorylation, and a tight control of intra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071941/ https://www.ncbi.nlm.nih.gov/pubmed/33912577 http://dx.doi.org/10.3389/fmed.2021.643686 |
_version_ | 1783683815204454400 |
---|---|
author | Wlazlo, Ewa Mehrad, Borna Morel, Laurence Scindia, Yogesh |
author_facet | Wlazlo, Ewa Mehrad, Borna Morel, Laurence Scindia, Yogesh |
author_sort | Wlazlo, Ewa |
collection | PubMed |
description | Nephritis is a common manifestation of systemic lupus erythematosus, a condition associated with inflammation and iron imbalance. Renal tubules are the work horse of the nephron. They contain a large number of mitochondria that require iron for oxidative phosphorylation, and a tight control of intracellular iron prevents excessive generation of reactive oxygen species. Iron supply to the kidney is dependent on systemic iron availability, which is regulated by the hepcidin-ferroportin axis. Most of the filtered plasma iron is reabsorbed in proximal tubules, a process that is controlled in part by iron regulatory proteins. This review summarizes tubulointerstitial injury in lupus nephritis and current understanding of how renal tubular cells regulate intracellular iron levels, highlighting the role of iron imbalance in the proximal tubules as a driver of tubulointerstitial injury in lupus nephritis. We propose a model based on the dynamic ability of iron to catalyze reactive oxygen species, which can lead to an accumulation of lipid hydroperoxides in proximal tubular epithelial cells. These iron-catalyzed oxidative species can also accentuate protein and autoantibody-induced inflammatory transcription factors leading to matrix, cytokine/chemokine production and immune cell infiltration. This could potentially explain the interplay between increased glomerular permeability and the ensuing tubular injury, tubulointerstitial inflammation and progression to renal failure in LN, and open new avenues of research to develop novel therapies targeting iron metabolism. |
format | Online Article Text |
id | pubmed-8071941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80719412021-04-27 Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis Wlazlo, Ewa Mehrad, Borna Morel, Laurence Scindia, Yogesh Front Med (Lausanne) Medicine Nephritis is a common manifestation of systemic lupus erythematosus, a condition associated with inflammation and iron imbalance. Renal tubules are the work horse of the nephron. They contain a large number of mitochondria that require iron for oxidative phosphorylation, and a tight control of intracellular iron prevents excessive generation of reactive oxygen species. Iron supply to the kidney is dependent on systemic iron availability, which is regulated by the hepcidin-ferroportin axis. Most of the filtered plasma iron is reabsorbed in proximal tubules, a process that is controlled in part by iron regulatory proteins. This review summarizes tubulointerstitial injury in lupus nephritis and current understanding of how renal tubular cells regulate intracellular iron levels, highlighting the role of iron imbalance in the proximal tubules as a driver of tubulointerstitial injury in lupus nephritis. We propose a model based on the dynamic ability of iron to catalyze reactive oxygen species, which can lead to an accumulation of lipid hydroperoxides in proximal tubular epithelial cells. These iron-catalyzed oxidative species can also accentuate protein and autoantibody-induced inflammatory transcription factors leading to matrix, cytokine/chemokine production and immune cell infiltration. This could potentially explain the interplay between increased glomerular permeability and the ensuing tubular injury, tubulointerstitial inflammation and progression to renal failure in LN, and open new avenues of research to develop novel therapies targeting iron metabolism. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071941/ /pubmed/33912577 http://dx.doi.org/10.3389/fmed.2021.643686 Text en Copyright © 2021 Wlazlo, Mehrad, Morel and Scindia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Wlazlo, Ewa Mehrad, Borna Morel, Laurence Scindia, Yogesh Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title | Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title_full | Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title_fullStr | Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title_full_unstemmed | Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title_short | Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis |
title_sort | iron metabolism: an under investigated driver of renal pathology in lupus nephritis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071941/ https://www.ncbi.nlm.nih.gov/pubmed/33912577 http://dx.doi.org/10.3389/fmed.2021.643686 |
work_keys_str_mv | AT wlazloewa ironmetabolismanunderinvestigateddriverofrenalpathologyinlupusnephritis AT mehradborna ironmetabolismanunderinvestigateddriverofrenalpathologyinlupusnephritis AT morellaurence ironmetabolismanunderinvestigateddriverofrenalpathologyinlupusnephritis AT scindiayogesh ironmetabolismanunderinvestigateddriverofrenalpathologyinlupusnephritis |